Compounded GLP-1: The Legal Status, Explained | telos rx
An open notebook and pen on a calm desk
← Back to blog

Compounded GLP-1 Medication: The Legal Status, Explained

By TelosRX Editorial Team Updated

Compounded GLP-1 medication is legal in the United States when a licensed pharmacy prepares it for an individual patient against a valid prescription. That is the whole basis of it. Compounded medication is not FDA-approved, which is a different statement from illegal, and the difference is where most of the confusion lives. TelosRX works with licensed partner compounding pharmacies and is LegitScript-certified.

The short answer

Legal, regulated, and not FDA-approved, all at once. Pharmacy compounding is governed by federal and state law. It produces medication tailored to a patient rather than mass-manufactured products, so it is not reviewed and approved the way a branded drug is. The legitimacy test is the pharmacy, the prescriber and the prescription.

Start your intake →

What compounding actually is

Compounding is pharmacy practice, not manufacturing. A licensed pharmacist prepares a medication to meet the needs of a specific patient, working from a prescriber's order.

It predates the modern drug industry. Before commercial mass production, nearly all medication was compounded. The practice survived because patients still need things the commercial market does not offer.

A patient who cannot swallow a tablet needs a liquid. A patient allergic to a dye or filler needs it removed. A patient who needs a strength that is not commercially made needs it prepared. Those are ordinary, legal, everyday pharmacy needs.

GLP-1 compounding sits in the same legal framework. The molecules involved, semaglutide and tirzepatide, are the same molecules studied and used in medicine. What differs is who prepares the final product and under what authority.

Why "not FDA-approved" is not the same as "not legal"

This is the single most misunderstood point in the whole category, and it is worth slowing down on.

FDA approval is a product-specific review. A manufacturer submits data for one exact formulation, at defined strengths, for defined uses. The agency reviews it and approves that product.

Compounded preparations are made one prescription at a time. There is no single fixed product to submit, so they are not put through that review. Federal law recognises compounding as legitimate pharmacy practice and regulates it through a separate route.

So compounded medication is not FDA-approved. It is also not illegal, not counterfeit, and not unregulated. Pharmacies are licensed by their state boards, inspected, and subject to federal requirements on ingredients and practices.

The FDA publishes a plain-language explanation of how this works in its overview of drug compounding. It is the most useful single page on the subject.

Key takeaway: Legality here is about the pharmacy, the prescriber and the prescription. It is not about whether the specific vial went through a product approval, because compounded preparations never do.

The shortage era and what changed after it

For a stretch, demand for branded GLP-1 medication outran supply and the FDA listed these molecules as being in shortage. During a listed shortage, compounding of copies is permitted more broadly.

Those shortage listings were resolved. A lot of headlines treated that as the end of compounded GLP-1 medication. It was not, but it did change the terms.

What continues legitimately is compounding that produces something genuinely tailored to the patient rather than a straight copy of a commercial product. That can mean a different strength, a different combination, or a different route of administration.

That is why the serious telehealth services shifted toward personalised formulations rather than pretending nothing happened. Compounded semaglutide from as low as $99 a month and compounded tirzepatide from as low as $139 a month are dispensed on that basis, always against an individual prescription.

Start an online visit if you want a provider to assess whether you qualify.

The three things that make it legitimate

Forget the acronyms. If you want to judge whether a compounded GLP-1 offer is above board, there are three questions.

First, is there a real prescriber? A licensed clinician must evaluate you and write the prescription. If a site will sell you the medication without any medical review, that is not compounding. That is something else.

Second, is there a licensed pharmacy? Compounded medication must be prepared by a pharmacy licensed by a state board, subject to inspection. Research-use-only peptide sellers are not pharmacies and their products are not for human use.

Third, is the prescription for you specifically? Compounding is patient-specific by definition. Bulk sales of unlabelled vials are outside the framework entirely.

TelosRX meets all three. Intake is asynchronous and takes about five minutes, a US-licensed provider reviews it, often within hours, and any prescription is subject to medical approval by a licensed provider.

What LegitScript certification adds

LegitScript is an independent certification body used by the major advertising platforms to decide which healthcare businesses they will allow to advertise.

Getting certified means submitting licensing, pharmacy relationships, prescribing practices and marketing claims for review. It is renewed, not granted once. It is also revocable.

It is not a government approval and it does not make compounded medication FDA-approved. What it does is give you an outside party that has actually looked at the operation. In a category with plenty of grey-market sellers, that is a meaningful filter.

TelosRX holds that certification. So do a handful of other serious operators. A great many websites selling these molecules do not.

Begin your evaluation with a certified service rather than an anonymous one.

Where the genuine legal risk sits

The risk is almost never the patient. It is the seller, and by extension the product you receive.

Grey-market peptide sites sell vials labelled for research use only. That labelling exists precisely because the product is not authorised for human use. Buying from them puts you outside any pharmacy framework, with no prescriber, no sterility assurance and no recourse.

Imported products are a second problem. Personal importation rules are narrow and do not cover ordering injectables from an overseas seller because it is cheaper.

The FDA has published specific warnings about unapproved GLP-1 products sold outside the pharmacy system. Its page on concerns with unapproved GLP-1 drugs is worth reading before ordering from anywhere unfamiliar.

The distinction is not compounded versus branded. It is inside the pharmacy system versus outside it.

State rules and why they matter to you

Pharmacy is regulated state by state as well as federally. Boards of pharmacy license the pharmacies. Medical boards license the prescribers. Telehealth rules differ by state.

In practice this means availability can vary. A legitimate service will tell you during intake if it cannot serve your state rather than taking your money first.

It also means the prescriber who reviews your intake must be licensed where you are. That is a real constraint and a good sign when a service respects it.

If you are declined, you pay nothing. That is the policy at TelosRX and it is a reasonable thing to expect anywhere.

What you are entitled to ask for

Being a patient in this category means you can ask questions, and a legitimate service will answer them.

Ask which pharmacy prepares your medication and where it is licensed. Ask whether the preparation is tested for sterility and potency. Ask who your prescriber is and where they hold a licence. Ask what happens if you want to stop.

None of those questions should produce a shrug. Vagueness on any of them is the clearest warning sign available to a non-expert.

You are also entitled to a real relationship rather than a transaction. Unlimited care team messaging, quarterly labs, dose adjustments and cancel anytime with no fee are the features that turn a shipment into care.

Free two-day shipping and FSA or HSA eligibility are practical details, but the substantive ones are clinical. A service that only sells you vials is not doing the part that matters.

If any of that is missing where you are currently buying, it is worth moving. Start your online visit and see the difference in how the intake is handled.

Formats, and how they relate to the legal picture

Personalisation is the legal heart of compounding, and it shows up in the formats available.

A microdosed tirzepatide protocol, as low as $116 a month, uses smaller increments than a standard titration. Some people tolerate that far better.

A needle-free oral GLP-1 from $9 a day dispenses oral semaglutide or oral tirzepatide, depending on what the clinician decides suits you. It is a different route of administration rather than a copy of an injection.

These are the kinds of preparations compounding exists to make possible. See whether the needle-free option fits you.

Start your treatment →

Frequently Asked Questions

Is compounded semaglutide legal?

Yes, when a licensed pharmacy prepares it for an individual patient against a valid prescription from a licensed prescriber. That is ordinary pharmacy practice governed by federal and state law. It is not FDA-approved, because compounded preparations are made one prescription at a time and are not submitted for product approval.

Why is compounded medication not FDA-approved?

FDA approval reviews one exact commercial formulation submitted by a manufacturer. Compounded preparations are made individually for patients, so there is no single fixed product to review. Federal law regulates compounding through a separate route, using pharmacy licensing, inspection and ingredient requirements instead.

Did compounded GLP-1 medication become illegal after the shortages ended?

No. What changed is the scope. Broad copying of a commercial product was permitted more freely during a listed shortage. Compounding that produces a genuinely personalised preparation for an individual patient continues under the ordinary rules, still requiring a prescription and a licensed pharmacy.

How can I tell if a compounded GLP-1 seller is legitimate?

Ask three questions. Is a licensed clinician evaluating you and writing a prescription. Is a state-licensed pharmacy preparing the medication. Is the prescription written for you specifically. If any answer is no, you are outside the pharmacy framework and should not order.

Are research-use-only peptides the same thing?

No, and this is the important distinction. Research-use-only vials are not prepared by a pharmacy, not dispensed against a prescription, and not intended for human use. That labelling is a legal signal, not a formality. Products sold that way sit entirely outside the compounding framework.

Does LegitScript certification mean the medication is approved?

No. LegitScript is an independent certification of the business, not a government approval of the product. It reviews licensing, pharmacy relationships, prescribing practice and claims, and it can be revoked. It is a useful filter in a category with many grey-market sellers.

TelosRX is LegitScript-certified. Compounded medication is not FDA-approved and is prepared by partner compounding pharmacies under federal compounding regulations. This article is general information, not medical advice, and does not replace guidance from your own provider. Approval is subject to evaluation by a licensed provider, and approval is not guaranteed. Individual results vary. TelosRX operates as an online-first, asynchronous telehealth service.

Questions about how this works? Message the TelosRX care team or start your evaluation at TelosRX.

Related research

Compounded medications are compounded, not FDA-approved. Prescriptions are never automatic or guaranteed. TelosRX operates under LegitScript-certified telehealth standards as an online-first, asynchronous telehealth service.

Read more from TelosRX